World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
100
Citations
39091
World Ranking
8247
National Ranking
4272

James T. Rosenbaum publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where James T. Rosenbaum sits on this spectrum.

101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 611 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101 publications 1,796+

This scientist: 670 publications — 78th percentile

78% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

James T. Rosenbaum D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where James T. Rosenbaum sits on this spectrum.

70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 400 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70 D-Index 217+

This scientist: 100 D-Index — 60th percentile

60% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

Research.com Recognitions

  • Member of the Association of American Physicians
  • Member of the Association of American Physicians

Overview

James T. Rosenbaum is affiliated with Oregon Health & Science University in the United States and has a significant research footprint in the field of medicine, with a particular focus on ophthalmology and rheumatology. Their scholarly work includes an extensive number of publications spanning various subfields including epidemiology, physiology, and immunology.

Their research topics notably encompass ocular diseases and Behçet's syndrome, systemic lupus erythematosus, retinal and optic conditions, spondyloarthritis studies and treatments, retinal diseases and treatments, sarcoidosis and beryllium toxicity research, as well as dermatology and skin diseases.

Frequent coauthors collaborating with James T. Rosenbaum include:

  • Eric B. Suhler
  • John H. Kempen
  • Jennifer E. Thorne
  • Douglas A. Jabs
  • H. Nida Sen

They have published extensively in several scientific journals. The most frequent publication venues for their work are:

  • American Journal of Ophthalmology
  • Annals of the Rheumatic Diseases
  • Arthritis & Rheumatology
  • Ocular Immunology and Inflammation
  • The Journal of Rheumatology

Recent papers authored or coauthored by James T. Rosenbaum include:

  • "American College of Rheumatology, American Academy of Dermatology, Rheumatologic Dermatology Society, and American Academy of Ophthalmology 2020 Joint Statement on Hydroxychloroquine Use With Respect to Retinal Toxicity," 2021, Arthritis & Rheumatology
  • "Genomewide Association Study of Acute Anterior Uveitis Identifies New Susceptibility Loci," 2020, Investigative Ophthalmology & Visual Science
  • "Consensus Recommendations for the Diagnosis of Vitreoretinal Lymphoma," 2021, Ocular Immunology and Inflammation
  • "Incidence of Uveitis in Secukinumab-treated Patients With Ankylosing Spondylitis: Pooled Data Analysis From Three Phase 3 Studies," 2020, ACR Open Rheumatology
  • "Tofacitinib as a Steroid-Sparing Therapy in Pulmonary Sarcoidosis, an Open-Label Prospective Proof-of-Concept Study," 2021, Lung

Among their recognitions, James T. Rosenbaum holds membership in the Association of American Physicians.

Best Publications

  • Standardization of uveitis nomenclature for reporting clinical data. Results of the First International Workshop.

    Douglas A Jabs;Robert B Nussenblatt;James T Rosenbaum

  • Guidelines for the use of immunosuppressive drugs in patients with ocular inflammatory disorders: recommendations of an expert panel

    Douglas A. Jabs;James T. Rosenbaum;C.Stephen Foster;Gary N. Holland

  • Endotoxin-induced uveitis in rats as a model for human disease.

    J. T. Rosenbaum;H. O. McDevitt;R. B. Guss;P. R. Egbert

  • American College of Rheumatology/Spondylitis Association of America/Spondyloarthritis Research and Treatment Network 2015 Recommendations for the Treatment of Ankylosing Spondylitis and Nonradiographic Axial Spondyloarthritis.

    Michael M. Ward;Atul Deodhar;Elie A. Akl;Andrew Lui

  • Expert panel recommendations for the use of anti-tumor necrosis factor biologic agents in patients with ocular inflammatory disorders.

    Grace Levy-Clarke;Douglas A. Jabs;Russell W. Read;James T. Rosenbaum

  • Differential efficacy of tumor necrosis factor inhibition in the management of inflammatory eye disease and associated rheumatic disease.

    Justine R. Smith;Ralph D. Levinson;Gary N. Holland;Douglas A. Jabs

  • Mast cells are a major source of basic fibroblast growth factor in chronic inflammation and cutaneous hemangioma.

    Zhenhong Qu;J. M. Liebler;M. R. Powers;T. Galey

  • Epidemiology and Course of Disease in Childhood Uveitis

    Janine A. Smith;Friederike Mackensen;H. Nida Sen;Julie F. Leigh

  • A Prospective Trial of Infliximab Therapy for Refractory Uveitis: Preliminary Safety and Efficacy Outcomes

    Eric B. Suhler;Justine R. Smith;Michael S. Wertheim;Andreas K. Lauer

  • Methotrexate for Ocular Inflammatory Diseases

    Sapna Gangaputra;Sapna Gangaputra;Craig W. Newcomb;Teresa L. Liesegang;R. Oktay Kaçmaz

  • Do tumor necrosis factor inhibitors cause uveitis? A registry-based study.

    Lyndell L. Lim;Lyndell L. Lim;Frederick W. Fraunfelder;James T. Rosenbaum

  • Mycobacterial diseases and antitumour necrosis factor therapy in USA.

    KL Winthrop;R Baxter;L Liu;CD Varley

  • In vivo effects of antibodies to immune response gene products: prevention of experimental allergic encephalitis.

    Lawrence Steinman;James T. Rosenbaum;Subramaniam Sriram;Hugh O. McDevitt

  • Role of intravitreal methotrexate in the management of primary central nervous system lymphoma with ocular involvement

    Justine R Smith;James T Rosenbaum;David J Wilson;Nancy D Doolittle

  • Azathioprine for Ocular Inflammatory Diseases

    Sirichai Pasadhika;John H. Kempen;Craig W. Newcomb;Teresa L. Liesegang

  • Local proliferation of fibroblast-like synoviocytes contributes to synovial hyperplasia. Results of proliferating cell nuclear antigen/cyclin, c-myc, and nucleolar organizer region staining.

    Zhenhong Qu;Cesar Hernandez Garcia;Leslie M. O'Rourke;Stephen R. Planck

  • HLA-B27 and Human β2-Microglobulin Affect the Gut Microbiota of Transgenic Rats

    Phoebe Lin;Mary Bach;Mark Asquith;Aaron Y. Lee

  • Does the Urinary Microbiome Play a Role in Urgency Urinary Incontinence and Its Severity

    Lisa Karstens;Mark Asquith;Sean Davin;Patrick Stauffer

  • American College of Rheumatology/Spondylitis Association of America/Spondyloarthritis Research and Treatment Network 2015 Recommendations for the Treatment of Ankylosing Spondylitis and Nonradiographic

    Michael M. Ward;Atul Deodhar;Elie A. Akl;Andrew Lui

  • Methotrexate for Ocular Inflammatory Diseases

    G. A. Levy-Clarke;S. Gangaputra;C. W. Newcomb;D. A. Jabs

Frequent Co-Authors

Stephen R. Planck
Stephen R. Planck Oregon Health & Science University
Douglas A. Jabs
Douglas A. Jabs Johns Hopkins University School of Medicine
Jennifer E. Thorne
Jennifer E. Thorne Johns Hopkins University
Robert B. Nussenblatt
Robert B. Nussenblatt National Institutes of Health
C. Stephen Foster
C. Stephen Foster Harvard University
Hans E. Grossniklaus
Hans E. Grossniklaus Emory University
Andrew D. Dick
Andrew D. Dick University of Bristol
John C. Ansel
John C. Ansel Northwestern University
John D. Reveille
John D. Reveille The University of Texas Health Science Center at Houston
Gary N. Holland
Gary N. Holland University of California, Los Angeles

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring related online degrees can open up diverse career options in healthcare beyond the traditional path of becoming a doctor. For those interested in behind-the-scenes roles, studying medical billing and coding financial aid options allows you to pursue this essential profession without the burdensome costs, thanks to available scholarships and grants.

Nursing remains one of the most in-demand fields. Prospective nurses often ask, do you have to take a teas test for lpn? Fortunately, various accredited programs now offer entry without requiring the TEAS or HESI exams, making the path more accessible for many students.

If health administration interests you, earning a health care administration degree online can launch a career in management, policy, or leadership roles within the medical field. For registered nurses aiming to become nurse practitioners, there are also flexible rn to np bridge programs to accelerate your career. These online pathways make advancing in healthcare more achievable than ever before.

Best Scientists Citing James T. Rosenbaum

Trending Scientists

Recently Published Articles